key: cord-0963700-v636jdkb
authors: Fox, S. J.; Potu, P.; Srinivasan, R.; Lachmann, M.; Meyers, L. A.
title: The COVID-19 herd immunity threshold is not low: A re-analysis of European data from spring of 2020
date: 2020-12-03
journal: nan
DOI: 10.1101/2020.12.01.20242289
sha: 3696d32554dcad892a5c423ad6fb7e55db123693
doc_id: 963700
cord_uid: v636jdkb

The recent publication of the Great Barrington Declaration (GBD), which calls for relaxing all public health interventions on young, healthy individuals, has brought the question of herd immunity to the forefront of COVID-19 policy discussions, and is partially based on unpublished research that suggests low herd immunity thresholds (HITs) of 10-20%. We re-evaluate these findings and correct a flawed assumption leading to COVID-19 HIT estimates of 60-80%. If policymakers were to adopt a herd immunity strategy, in which the virus is allowed to spread relatively unimpeded, we project that cumulative COVID-19 deaths would be five times higher than the initial estimates suggest. Our re-estimates of the COVID-19 HIT corroborate strong signals in the data and compelling arguments that most of the globe remains far from herd immunity, and suggest that abandoning community mitigation efforts would jeopardize the welfare of communities and integrity of healthcare systems.

Given that this unpublished work is fundamentally shaping public discourse and global 24 policy, reconciling its claims with the rapidly evolving state of the pandemic is paramount. To 25 this end, we reevaluated the core model from the study and have identified a fundamental flaw 26 that leads to underestimation of the COVID-19 HIT. The authors sought to identify the cause of 27 the summer slowdown in four European countries by fitting an SEIR-like model of COVID-19 28 transmission to case count data up to July of 2020. The analysis is structured so that one of two 29 explanations are possible. Either the pandemic is self-limiting (i.e., the HIT is low) or social 30 distancing and other community mitigation efforts slowed transmission. However, teasing apart 31 the contributions of these factors from the case data alone is statistically impossible. In other 32 words, one cannot estimate the HIT without making assumptions about the efficacy of 33 community mitigation, and vice versa (See supplement). 34

So the researchers made a strong assumption about community mitigation efforts in 35

Europe in the spring and summer of 2020. Roughly, they assume that Europe locked down 36 throughout April and then returned to normal (linearly) by the end of August ( Figure 1A -Blue). 37

By assuming that interventions disappear steeply, the model concludes that the pandemic must 38 be fading due to immunity buildup, and thus estimates low HITs. As it turns out, the derived HIT 39 is highly sensitive to the assumed timeline of mitigation ( Figure 1A -Green), the COVID-19 HIT estimate increases six-fold for Belgium, three-fold for England, 45 ten-fold for Portugal, and six-fold for Spain ( Figure 1B) . A range of alternative scenarios produce 46 similar estimates ( Figure S2-S3 ). If policymakers were to adopt a herd immunity strategy, in 47 which the virus is allowed to spread relatively unimpeded, we project that cumulative COVID-19 48 deaths would total almost 650,000 (95% CI: 500,000 -780,000) across all four countries 49 through the end of the pandemic under the revised HIT estimates, roughly five-fold higher that 50 projected under the original low HIT estimates ( Figure S4 ). 51

The fragility of the Aguas et al. study 2 undermines a key premise of GBD and other 52 recent calls for "herd immunity" strategies. To their credit, the authors clearly demonstrate that 53 population heterogeneity in susceptibility to infection can dramatically lower the herd immunity 54 threshold 10 . However, their model can only disentangle the impacts of heterogeneity versus 55 interventions on COVID-19 transmission when approached with sufficient data and validated 56 assumptions. Our rough, but arguably more plausible, re-estimates of the COVID-19 HIT 57 corroborate strong signals in the data and compelling arguments that most of the globe remains 58 far from herd immunity. Moreover, abandoning community mitigation efforts would jeopardize 59 the welfare of communities and integrity of healthcare systems. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 3, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint analyzed data through July 10th, 2020 as in [1] . We made this adjustment to 33 address a strong tendency of the model to estimate a low HIT without evidence 34 of increased transmission following intense mitigation during the initial stay at The modeling framework fits the timing that mitigation begins and the max-48 imum impact it will have, but makes assumptions about the remaining parame-49 ters. Their framework assumes that once mitigation begins it will take 21 days 50 to reach a maximum level, will remain there for 30 days, and will subsequently 51 return to the original baseline level after 120 days. They test sensitivity to Figure S2 ) and times to return back to baseline ( Figure S3 ). It's clear that 58 the model is sensitive to the assumed shape of mitigation, with HIT estimates 59 ranging from almost 5% to 85% depending on the country and assumed shape. 60 It is clear that the estimated HITs are extremely sensitive to these assump-61 tions, and that there are many combinations of heterogeneity and mitigation 62 progression that can give similar fits (described in the next section), so it is 63 extremely important that the assumed mitigation curves match reality. While CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; Figure S1 : Country-specific case counts used for fitting alongside daily estimates of the effective reproduction number. Case counts in black indicate data used that are the same as Aguas et al, and light grey indicates the additional data we included in our fitting procedure as described in the modifications section of the supplement. mated time to completely remove mitigation according to the government re-75 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; Figure S4 : Mortality estimate for a herd immunity strategy for each of the four European countries and the United States. Comparison between estimated mortality if herd immunity thresholds are as low as estimated in Aguas et al (Blue), versus those estimated using the policy-based, alternative mitigation curve (Green). Estimates assume an infection fatality rate of 0.68% (95% CI: 0.53%-0.82%) [10] 5 Non-identifiability of the model CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint

Then,

where R 0 is the basic reproduction number, R t = R eff (t) is the effective repro- 

where F t (S) is some functional of the variable susceptibility S t (x) as a function 7 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint Taking integrals, it can be shown that

Using the previous formula, we have that S t = (S t ) 

Assume that F t and R t are given. Then M σ can be calculated as

Let us write script letters for log of the values:

Since F t (S) = (S t ) (a+1)/a , we have that F σ = (1 − σ) (a+1)/a . Therefore, F σ = 157 a+1 a log(1 − σ) and

As before, herd immunity is reached at the value S * of S at which no growth 159 occurs in the absence of intervention, i.e., R t /M t ≡ R * /M * = 1. That is, 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint Taking logarithms, we find that

Finally, substituting this into the expression above above we get

Inverting the mapping t → σ, we can again write this as a function of time t:

Exponentiating both sides, we finally arrive at the expression . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint rates estimated in Aguas et al. to estimate the true incidence of disease each 188 day, which we converted to S t using S t = S t−1 − C t /ρ. Here, C t is the number 189 of the reported cases in that country at time t, and ρ is the country-specific 

In Figure S5 we show the calculated mitigation curves for each country across 193 a range of potential HITs from 20% to 70%. 194 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 3, 2020. Figure S5 : Using cases data and R t estimation we calculate M t , the NPI transmission multiplier timelines that would be inferred to have a predetermined HIT.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.01.20242289 doi: medRxiv preprint

Herd immunity thresholds for SARS-CoV-2 esti-196 mated from unfolding epidemics

A mathematical model 200 reveals the influence of population heterogeneity on

SARS-CoV-2". en. In: Science 369.6505

COVID-19 herd immunity in the Brazilian Amazon

A New Framework and Software to Estimate Time-205

Varying Reproduction Numbers During Epidemics

COVID-19 herd immunity: 211 where are we?" en

Individual variation in susceptibility or ex-213 posure to SARS-CoV-2 lowers the herd immunity threshold

Oxford covid-19 government response tracker

Temporal dynamics in viral shedding and transmissibility of 219 COVID-19". en

Herd immunity -estimating the level required to halt 221 the COVID-19 epidemics in affected countries

A systematic review and meta-223 analysis of published research data on COVID-19 infection-fatality rates

The authors thank the authors of Aguas et al. 2 , for sharing their research code and data, which 73